Patentable Subject Matter at Berkeley

Patentable Subject Matter in the Health Sciences:
Diagnostics & DNA

April 5, 2012
Registration 3:30 – 4:00 pm
Panel Discussion 4:00 – 6:00 pm
Reception 6:00 – 7:00 pm

Berkeley Law – Warren Room
Berkeley, CA

BCLT will host a panel discussion of issues of great importance to healthcare and biotechnology: the patentabilty of Diagnostic methods and DNA. The discussion will focus on the doctrinal and societal implications of two current cases: Prometheus v Mayo and AMP v Myriad. In the recent Prometheus case, the US Supreme Court held that a claim that covers specific correlations between blood test results and patient health is not eligible for patent protection. In the Myriad case, a pending petition for certiorari seeks Supreme Court review of the Federal Circuit decision overturning a summary judgment ruling that various claims to DNA lack patent-eligibility. Panelists will include Professors Robert Merges and Talha Syed of Berkeley Law, Professor Rebecca Eisenberg of Michigan Law, and Professor Robin Feldman of Hastings. A reception will follow.

Visit the conference page for more information: